TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Maximum Plasma Concentration Cmax (ug/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative number of clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in average voided volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to first recurrence event
Endpoint domain: Mortality/survival
Primary endpoint: Acceptability among participants about carrying the GPS logging device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety (vitals, labs, PE, ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: LAK cytotoxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HAART-free time interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mortality due to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: COVID-19 Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cartilage processing time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Objective Quality of Reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cellular Immune Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Late Adverse Events Relating to the Device
Endpoint domain: Adverse events/effects
Primary endpoint: Late Efficacy Issues Regarding Patent Ductus Arteriosis (PDA) Closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: punctal opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minnesota Living with Heart Failure Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: % of patients with Bactericidal titers > 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of fingerstick whole blood DBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of fingerstick whole blood DBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of venous whole blood DBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of venous whole blood DBS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores obtained with Benton test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of Airway Assistance
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of neutrophil engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maternal Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal Morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG Power During Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG Power Examined Before Arousal From Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: EEG Power Examined as Subjects Fall Asleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants With a Diagnosis of Rheumatoid Arthritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Discontinued Due to Lack of Efficacy
Endpoint domain: Adverse events/effects
Primary endpoint: Implant cut-out
Endpoint domain: Adverse events/effects
Primary endpoint: Resting thickness transversus abdominis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contracted thickness transversus abdominis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in FD Symptoms Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in FDQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: failure of empiric outpatient antibiotic therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Insulin sensitivity index (HOMA-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in blood glucose variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Alzheimer Disease Assessment Scale-cognitive subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in rate of conversion to dementia
Endpoint domain: Mortality/survival
Primary endpoint: Ceftolozane Clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of tumors collected
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Restorations Scoring Alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawal Symptoms Measured Using the Clinical Institute Withdrawal Assessment for Alcohol-Revised (CIWA-Ar)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Area Above Basal (AAB) for Glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RSBI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of participants compliant with supportive care visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Augmentation Index (arterial stiffness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ENDO-PAT (Peripheral Arterial Tone) score (endothelial function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in FEV1/FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in MVV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline in rectal functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change from baseline in urinary function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative Delirium Incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative Cognitive Decline
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Intraoperative Burst Suppression Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of Seizure Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reliability of FN scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: internal consistency of FN scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: measurement error of FN scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: structural validity of FN scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: responsiveness of FN scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptability of FN scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: total intraoperative opioid consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective complaints of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of inhalations on Iloprost 10 ug/mL and 20 ug/mL
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of delivered doses (none/partial/full) on Iloprost 10 ug/mL and 20 ug/mL
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Pathological impact
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects reporting any serious adverse events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: number of drug targetable genetic changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Antioxidant capacity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in breakpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in FBS values at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in HbA1c values at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Outpatient compliance with protein calorie restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comparison of H2S and related biological markers of stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Unexpected Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: clinical tumor regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC0-∞) of dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration (Cmax) of dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the effect-time curve (AUEC0-48) of dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P.E.S.
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EIT images accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of Edema Increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of Dexamethasone (or Any Corticosteroid Administration With the Purpose of Treating Cerebral Edema)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fat graft resorption rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic post-surgical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rheumatoid Arthritis Magnetic Resonance Imaging Scoring System (RAMRIS) Synovitis Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OMERACT RAMRIS Bone Edema Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OMERACT RAMRIS Erosion Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clearance (CL) or apparent oral clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume of distribution (V) or apparent oral volume of distribution (V/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of attitudes pertaining to mental illness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Behaviors toward mental illness
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change From Baseline in Ankylosing Spondylitis Disease Activity Score (ASDAS) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Adverse Events (AE) During the Study Conduct
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Serious Adverse Events (SAEs) During the Study Conduct
Endpoint domain: Adverse events/effects
Primary endpoint: Baseline CTC count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: therapy responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heritability of renal hypodysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Overall User experience
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Longer-term safety
Endpoint domain: Adverse events/effects
Primary endpoint: Area Under the Concentration-time Curve of BI 409306 in Plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of mental disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Step Length Adaptation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Outcomes following cochlear implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of XCEL-MT-OSTEO-ALPHA
Endpoint domain: Adverse events/effects
Primary endpoint: feasibility of XCEL-MT-OSTEO-ALPHA
Endpoint domain: Resource use
Primary endpoint: total medication dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total Pain scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall satisfaction with pain control
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maternal Fetal Attachment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in 24-hour Pad Weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight reduction of 5% or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety and tolerability of TPI-1020
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients sent to an emergency department
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidence of Graded Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change of Salivary concentration of Xylitol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum calcium concentration (albumin-corrected)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urine calcium: creatinine ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Success or failure in identifying the sentinel node
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area Under the Serum Concentration of Follicle Stimulating Hormone (FSH) - Time Curve (AUC(0-192))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Maximum Serum Concentration of Follicle Stimulating Hormone (FSH) (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Choroidal blood flow during isometric exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Dose-related immunogenicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hospitalization for Heart Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Circumferential Contrast Spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Prompts Responded to
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Multicomponent Mental Health Literacy Measure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Help seeking intentions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of participants with genetic cause identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal aortic valve bioprosthesis leaflet mobility and morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SADE-free rate
Endpoint domain: Adverse events/effects
Primary endpoint: Vaginal recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Total 25-hydroxyvitamin D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Degree of Continuity between natural tooth structure and the restoration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Child Behavior Checklist Ages 1.5-5
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pediatric Evaluation of Disability Inventory
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Continuous Performance Test (CPT 3 or CPT-K 2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Responsiveness Scale™, Second Edition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Conners scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavior Rating Inventory of Executive Function (BRIEF-2)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Feasibility of community-based rapid HIV testing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Functional result of elbow (objective)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional result of elbow (subjective)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in selected clinical parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in selected laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in selected microbiologic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking bouts detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum non-targeted metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcriptome expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum targeted metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fugl-Meyer Lower Extremity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: One-hour steady-state plasma concentration of fluticasone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mammogram Completion at 6 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change from Baseline Gingival Recession Depth at 6 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Change from Baseline Keratinized Gingiva Height at 6 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Maximal percentage of pupil contraction and dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maximal velocity of pupil contraction and dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Latency of pupil contraction and dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Thumb Disability Examination (TDX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale - Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flexibility of the hamstring muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ambulatory systolic BP (SABP) reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in RR interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mitral regurgitant volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fixation disparity in arcMin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EAT volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score of skills in implementing one-hour bundle sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy assessed by Penile Doppler ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy assessed by SHIM/IIEF/EHS questionnaires
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mutations in calmodulin genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: donor site healing time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hard cardiac events (cardiac death or MI)
Endpoint domain: Mortality/survival
Primary endpoint: Post-operative febrile morbidity
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Skin Perfusion Pressure (SPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: voxel-wise MTR dynamic mapping of the lesions and NABT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes